Elevated C-reactive Protein Associates with Early-stage Carotid Atherosclerosis in Young Subjects with Type 1 Diabetes
Overview
Authors
Affiliations
Objective: To evaluate whether low-grade inflammation contributes to early-stage advanced carotid atherosclerosis in young subjects with type 1 diabetes.
Research Design And Methods: The mean and maximum (max) intima-media thicknesses (IMT) of the carotid artery were assessed using ultrasound B-mode imaging in 55 patients with type 1 diabetes (22 men and 33 women, aged 22.1 +/- 3.6 years (+/- SD), duration of diabetes 14.2 +/- 5.7 years) and 75 age-matched healthy nondiabetic subjects (28 men and 47 women). High-sensitive C-reactive protein (hs-CRP) levels were measured with a latex-enhanced immunonephelometer.
Results: The patients with type 1 diabetes had significantly higher hs-CRP levels (median 0.35, range 0.05-1.47 mg/l vs. median 0.14, range 0.05-1.44 mg/l; P = 0.001) as well as significantly higher mean IMT and max IMT than the nondiabetic subjects (mean IMT 0.76 +/- 0.09 vs. 0.72 +/- 0.04 mm, P = 0.003; max IMT 0.84 +/- 0.11 vs. 0.77 +/- 0.06 mm, P < 0.0001). Hs-CRP levels were significantly correlated with the mean and max IMT of patients with type 1 diabetes and with the max IMT of nondiabetic patients. Multivariate regression analyses for both diabetic and nondiabetic subjects as a single group showed that hs-CRP levels are independently correlated with the mean IMT and max IMT levels (P = 0.002 and P = 0.023, respectively) as well as with diastolic blood pressure, sex, and duration of diabetes.
Conclusions: Our data indicate that hs-CRP levels are elevated in young patients with type 1 diabetes, possibly corresponding with early-stage advanced carotid atherosclerosis.
Assessment of Nutrients Intake in Pediatrics with Type 1 Diabetes and Dyslipidemia in Jordan.
Tayyem R, Nawaiseh H, Zakarneh S, Khial Y, Allehdan S Adolesc Health Med Ther. 2024; 15:31-43.
PMID: 38529360 PMC: 10961238. DOI: 10.2147/AHMT.S439046.
Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights.
Jia G, Bai H, Mather B, Hill M, Jia G, Sowers J Int J Mol Sci. 2024; 25(2).
PMID: 38255878 PMC: 10815704. DOI: 10.3390/ijms25020804.
Targeting Inflammation in Diabetic Kidney Disease: Is There a Role for Pentoxifylline?.
Leehey D Kidney360. 2022; 1(4):292-299.
PMID: 35372914 PMC: 8809273. DOI: 10.34067/KID.0001252019.
Nakamura M, Sugiura M Antioxidants (Basel). 2022; 11(2).
PMID: 35204141 PMC: 8868069. DOI: 10.3390/antiox11020259.
Diabetes and hypertension: Pivotal involvement of purinergic signaling.
Reichert K, Castro M, Assmann C, Bottari N, Miron V, Cardoso A Biomed Pharmacother. 2021; 137:111273.
PMID: 33524787 PMC: 7846467. DOI: 10.1016/j.biopha.2021.111273.